Hepatocellular carcinoma suppressor 1 (HCCS1) was discovered as a novel tumor suppressor gene. We recently observed that adenovirus-mediated gene transfer of HCCS1 leads to cytotoxicity to human hepatocarcinoma cells. Here, we have demonstrated that adenovirus-mediated overexpression of HCCS1 induces apoptosis in hepatocarcinoma cells and have further characterized the apoptotic cascade. The results showed that lysosomal cathepsin D is released into the cytosol in response to HCCS1 overexpression and consequently triggers Bax insertion into the mitochondrial membrane, which leads to the release of cytochrome c. In addition, HCCS1 overexpression can induce an increase in intracellular free Ca 2 þ concentration, which also results in cytochrome c release. The released cytochrome c activates downstream caspases, leading to the occurrence of the late stages of apoptosis. Moreover, we demonstrated that the disruption of HCCS1 in mice leads to embryonic lethality, accompanied by abnormal labyrinth architecture resulting from the excessive proliferation of trophoblast cells in the placenta. These results suggest that HCCS1 plays a role in apoptosis regulation and development.
Hepatocellular carcinoma suppressor 1 (HCCS1) has been identified as a novel tumor suppressor gene candidate via screening of the minimum region of high-frequency LOH on chromosome 17p13.3 and positional cloning in hepatocellular carcinoma in our previous study. 1, 2 Our recent studies demonstrated that replication-deficient adenovirus-mediated gene transfer of HCCS1 significantly inhibited the growth of human hepatocarcinoma cells in vitro or in vivo (submitted for publication), suggesting that HCCS1 may behave as a negative regulator of cell proliferation. However, the possible mechanism of this regulation is unclear. Since apoptosis is believed to play an important role in the maintenance of homeostasis and the inhibition of tumorigenesis, in the present study, we focused on the role of HCCS1 in the induction of apoptosis.
Contrary to the previous study, 1 which highlighted HCCS1 as an important gene contributing to hepatocellular carcinoma tumorigenesis, another study regarding gene mutations and LOH suggested that the HCCS1 gene might be involved in the acceleration of the tumorigenic process and its mutation might not be the main mechanism of inactivation in the development of hepatocellular carcinoma. 3 Although the authors came up with certain explanations for this discrepancy, further studies are required to investigate the role of HCCS1 in vivo.
Here, we provide definite experimental evidence demonstrating that adenovirus-mediated overexpression of HCCS1 promotes apoptosis of human hepatocarcinoma cells.
Furthermore, we have characterized the HCCS1-mediated apoptotic cascade. Moreover, we aimed to generate HCCS1 knockout mice to study the in vivo role of HCCS1 but found that the disruption of HCCS1 leads to an unexpected embryonic lethality. Further studies on the histology of the placenta from HCCS1 heterozygous intercrosses suggested that disruption of normal labyrinth architecture that resulted from the excessive proliferation of trophoblast cells in the HCCS1 À/À placenta may be the cause of embryonic lethality.
Results
HCCS1 overexpression induces apoptosis in hepatocarcinoma cells via cytochrome c/caspase-9/caspase-3 pathway. Our recent studies have demonstrated that infection with a replication-deficient recombinant adenovirus expressing HCCS1 (Ad-HCCS1) leads to the overexpression of HCCS1 in human hepatocarcinoma cells (Supplementary Figure S1a) . Ad-HCCS1 exerted marked cytopathic effect against BEL7404 cells compared with Ad or Ad-EGFP, whereas the cytotoxic activity of Ad-EGFP was similar to that of Ad (Supplementary Figure S1b) . To determine the possible contribution of apoptosis to Ad-HCCS1-mediated cytotoxicity, BEL7404 cells were infected with Ad-HCCS1 or Ad at a multiplicity of infection of 50 and assessed by fluorescent-activated cell sorting (FACS) following Annexin V-FITC/prodiduim iodine (PI) staining. As shown in Figure 1a and b, Ad-HCCS1-infected BEL7404 cells exhibited a significant increase in Annexin V staining 48 h post-infection (81.6 ± 3.1% in Ad-HCCS1-infected cells compared with 3.6 ± 0.3% in untreated cells or 4.1 ± 0.2% in Ad-infected cells). The nuclear morphological changes in response to Ad-HCCS1 infection of BEL7404 hepatocarcinoma cells were then examined by fluorescence microscopy after staining with Hoechst33258. Pyknotic and karyorrhectic nuclei appeared 72 and 96 h after Ad-HCCS1 infection (Supplementary Figure S1c) . These results indicate that Ad-HCCS1 infection produces apoptosis in BEL7404 hepatocarcinoma cells. HCCS1-induced apoptosis was also supported by an increase in the nuclear staining observed after in situ TUNEL (terminal deoxynucleotidyltransferase (TdT)-mediated dUTP-biotin nick end-labeling) (Supplementary Figure S1d) . To evaluate the role of caspase in HCCS1-induced apoptosis, cleavages of several key components of the caspase family were detected by western blotting. As shown in Figure 1c , caspase-3 and -9, but not caspase-8 and -12 were processed beginning at 48 h after Ad-HCCS1 infection. There was no cleavage of any procaspases detected even 96 h after Ad infection. We then examined the cleavage of the known caspase substrate poly(ADP-ribose) polymerase (PARP); as expected, it was observed to be cleaved after the infection (Figure 1c) . To further discern the roles of caspases in HCCS1-induced apoptosis, we used the pan-caspase inhibitor z-VAD-fmk and a caspase-9 inhibitor z-LEDH-fmk. As shown in Figure 1d , both inhibitors provided significant protection from HCCS1-induced apoptosis.
To test whether cytochrome c is released from mitochondria during HCCS1-induced apoptosis, its cytosolic translocation was examined by western blot. As shown in Figure 1e , cytochrome c in the cytosol of Ad-HCCS1 infected cells was observed at 48 h after infection, and its levels significantly increased at 72 h. To see whether the release of cytochrome c is a consequence of mitochondrial membrane potential (Dc m ) loss, BEL7404 cells were infected with Ad or Ad-HCCS1, and then stained with JC-1, which reflects changes in Dc m as a fluorescence shift from orange to green, and analyzed by FACS. As shown in Figure 1f , there is a clear increase in the percentage of cells (lower right quadrants) that emitted only green fluorescence (representing cells with depolarized mitochondrial membranes) 72 h after Ad-HCCS1 infection. This observation supports the previous finding 4 that the release of cytochrome c can precede the loss of mitochondrial membrane potential in some apoptotic pathway.
HCCS1 overexpression induces activation of Bax that is not associated with Bid cleavage. Bax can fully integrate into the mitochondrial membrane and then facilitate the release of cytochrome c. 5, 6 Therefore, we investigated the subcellular distribution of Bax by western blot. Bax protein was not only found in the cytosol but also observed to be loosely associated with mitochondria in normal cells, and the mitochondrial membrane insertion of Bax was shown by its resistance to alkaline extraction similar to the mitochondrial protein Cox II. As shown in Figure 2a , Bax was inserted into the mitochondrial membrane of Ad-HCCS1-infected cells 36 h post-infection. Although mitochondrial Bax was also examined at an earlier time point, it could not be observed at the time point of 24 h post-infection (data not shown). The original p21 Bax was partially cleaved to p18 Bax, which has been demonstrated to accelerate the apoptotic process. 7 p18 Bax was observed at 60 h post-infection in the alkalineresistant fraction; however, the cleavage of Bax was not detected in the cytosol of Ad-HCCS1-infected cells (Figure 2a) . We then used the Bax-inhibiting peptide (BIP) V5, which inhibits Bax-mediated translocation of cytochrome c and suppresses mitochondria-dependent apoptosis. 8 As shown in Figure 2b , BIP V5 could effectively suppress apoptosis induced by Ad-HCCS1 infection.
Was Bid activated (tBid produced) and translocated to mitochondria together with Bax? In Ad-HCCS1-infected cells, Bid remained entirely confined to the cytosol as a full-length p22 protein (Figure 2c ). The results indicate that HCCS1 overexpression induces Bax insertion into the mitochondrial membrane that is not associated with the activation of Bid, and then initiates the apoptosis. Targeted disruption of HCCS1 leads to embryonic lethality. To elucidate the role of HCCS1 in vivo, we generated HCCS1-deficient mice by gene targeting in ES cells. We replaced exons 1 and 2 with a neomycin resistance (neo r ) gene (Figure 5a ) and identified the targeted ES cell clones with Southern blot analysis using probes external to the targeting construct (Figure 5b ). Targeted ES cell clones contributed to the germ line of chimeric mice and generated HCCS1 heterozygous null mice (HCCS1 þ /À ). Heterozygous male and female mice displayed no overt phenotype and were fertile. However, we were unable to identify a single HCCS1 homozygous mouse (HCCS1 À/À ) among the 111 offspring born from the crosses between HCCS1 heterozygous mice. The surviving pups were either HCCS1 þ / þ (33 of 111) or HCCS1 þ /À (78 of 111). These results represent the Mendelian ratio of mutant and wild-type To determine the timing of this lethality, we isolated and genotyped embryos (Figure 5c ) at various gestational days. It was found that HCCS1 À/À embryos died before embryonic day (E)12.5 and were small and developmentally retarded compared with their littermate controls beginning on E7.5.
The comparison between HCCS1
À/À and HCCS1 þ / þ embryos at E9.5 is shown in Figure 5d .
The embryonic lethality of HCCS1-null mice possibly due to abnormal labyrinth architecture in the placenta. To test whether there is any defect in the HCCS1 À/À placenta, a histological examination of the placenta from the HCCS1 heterozygous intercrosses was performed. Hematoxylin-and eosin-stained sections demonstrated that the wild-type labyrinth had a porous appearance-with trophoblast cells being well organized and distributed around the fetal and maternal blood vessels at E10.5-that facilitated the exchange of oxygen and nutrients between the mother and the fetus. However, the HCCS1 mutant labyrinth layer was severely disrupted with an accumulation of large clusters of densely packed trophoblast cells at the expense of maternal and fetal blood spaces (Figure 6a and b) . The differences between HCCS1 mutant and wild-type placentae was observed at E9.5 (data not shown). In the wild-type placenta, trophoblast cells lining the maternal blood spaces appeared elongated and thin and expressed endogenous alkaline phosphatase activity at the brush border. Therefore, we further characterized the decrease in maternal and fetal blood spaces by analyzing the alkaline phosphatase-positive cells, which reflect the trophoblast transport surface area within the labyrinth. It was shown that the trophoblast transport surface area within the HCCS1-deficient placental labyrinth was significantly reduced, indicating a considerably less extensive villous structure (Figure 6c ). Furthermore, we measured cellular proliferation in HCCS1 þ / þ and HCCS1 À/À placentae by proliferation cell nuclear antigen (PCNA) immunohistochemical staining. Analysis of the labyrinth from E10.5 placentae indicated that HCCS1 À/À trophoblast cells had a markedly increased expression of PCNA than wild-type littermate controls (Figure 6d ). Taken together, our results suggest that the embryonic lethality of HCCS1 À/À mice probably results from the excessive proliferation of trophoblast cells, which disrupts the normal labyrinth architecture and decreases vascularization in the placenta.
Discussion
In this study, we identified the role of apoptosis in HCCS1 overexpression-mediated cytotoxicity and further investigated the possible molecular mechanism of HCCS1-induced apoptosis. It was shown that Ad-HCCS1 infection induces the lysosomal disintegration and the release of cathepsin D to the cytosol. Released cathepsin D leads to the mitochondrial translocation of Bax and the release of cytochrome c followed by the activation of caspase-9 and -3. The release of cytochrome c also results from the elevation of [Ca Lysosomal cathepsins have been shown to be readily translocated to the cytosol and to mediate apoptosis in response to various stimuli. 9 Further, released cathepsin D, an aspartic protease, has been reported to trigger Bax activation, which is not associated with Bid activation and result in selective AIF release. 10 This pathway was partially supported by our results suggesting that released cathepsin D triggers the insertion of Bax into mitochondrial membranes without the cleavage of Bid. The release of cathepsin D following lysosomal permeabilization constitutes an initial step in the HCCS1-induced apoptotic cascade. Since cathepsin D has been demonstrated to remain active at a neutral pH, 10 extralysosomal cathepsin D in Ad-HCCS1-infected cells might activate Bax by degrading cytosolic chaperones, including certain isoforms of cytosolic 14-3-3 proteins and the Ku70 protein, which sequester Bax in an inactive conformation in healthy cells and undergo dissociation during apoptosis. 11, 12 Inconsistent with the previous pathway, 10 our experiments highlighted that the release of cytochrome c, but not AIF, is the central event of apoptotic cascades in response to HCCS1 overexpression. AIF can cause apoptotic cell death once it translocates from the mitochondria to the nucleus. 13 Although AIFs were released from mitochondria following Ad-HCCS1 infection, the nuclear translocation of AIF was not detected even when HCCS1-induced pyknosis was observed. And the AIF inhibitor N-phenylmaleimide 14 could not protect cells from HCCS1-induced apoptosis (Supplementary Figure S2) . These results suggest that AIF is not involved in HCCS1-induced apoptosis. We also measured the Dc m changes of the cells infected with Ad-HCCS1. It remains uncertain whether the loss of Dc m occurs as an initiator, or an effect of apoptosis, or is actually necessary of apoptosis induction to occur. Although the dissipation of Dc m was shown to be a requirement for cytochrome c release from the mitochondria, 15, 16 other studies [17] [18] [19] suggest that the loss of Dc m occurs secondary to cytochrome c release and that Bax participation may be a more plausible candidate for cytochrome c release than Dc m . In our system, it was showed that HCCS1 overexpression induced cytochrome c release following Bax translocation but without obvious depolarized mitochondrial membranes. Since the disruption of Dc m may appear to be responsible for the release of AIF into the cytosol, 17 one can conceive that the loss of Dc m followed by AIF release may be a subsequent event in the HCCS1-induced apoptotic pathway.
Elevation of [Ca 2 þ ] i can trigger the release of mitochondrial cytochrome c and the activation of caspases. 20 The Ca 2 þ -induced apoptotic cascade may be associated with activated Ca 2 þ -sensitive enzymes. Calpain, a calcium-dependent cysteine protease, has been shown to be associated with Ca 2 þ -induced apoptosis. 21 Although chelation of intracellular Ca 2 þ did not prevent staurosporine-induced Bax translocation to mitochondria, 22 it was reported that calpain could cleave Bax to p18 Bax to enhance Bax-induced apoptosis. 7, 23 Therefore, we measured the [Ca 2 þ ] i of Ad-HCCS1-infected cells to investigate its role in HCCS1-induced apoptosis. The results showed that HCCS1 overexpression led to an early increase of [Ca 2 þ ] i . Buffering of cytosolic Ca 2 þ by Bapta-AM could block the release of cytochrome c and alleviate apoptosis following Ad-HCCS1 infection, but it had no effect on the translocation of Bax or on its cleavage (Supplementary Figure S3c) . This was supported by the observation that the On the other hand, we generated knockout mice to investigate the in vivo role of HCCS1 in tumorigenesis. However, HCCS1 mutant embryos unexpectedly suffered death by E12.5. Survival and growth of the fetus are still critically dependent on the placenta. Inactivation of various genes, including several tumor suppressor genes, leads to embryonic lethality as a result of abnormal placental development. 24 For example, it was demonstrated that inactivation of the retinoblastoma (Rb) gene leads to embryonic lethality. 25 Further investigations on Rb-deficient placentae showed that the loss of Rb leads to excessive proliferation of trophoblast cells and a severe disruption of the normal labyrinth architecture in the placenta. The defect in Rb-deficient placentae results in a decreased surface area required for oxygen/nutrient exchange between the mother and the fetus. A similar alteration of the cellular architecture of the labyrinth was observed in HCCS1-deficient placentae, indicating that a defect in proliferation in HCCS1 À/À placental trophoblast cells may be the lethal cause of embryonic death in HCCS1 À/À mice. However, heterozygous HCCS1 mice had lived beyond 12 months without evidence of significant disease (data not shown), indicating that HCCS1 haploinsufficiency may not be a critical feature for normal HCCS1 function. Further analysis of HCCS1 homozygous mice, such as rescuing developing embryos from placental failure, should provide us with a better understanding of the role of HCCS1 in development and tumorigenesis.
Notably, HCCS1 is demonstrated to be a homologue of yeast Vps53 by cDNA sequence alignment. In yeast, Vps53 is a subunit of the Golgi-associated retrograde protein complex, which is involved in retrograde transport from the early and late endosome to the late Golgi. 26 Human Vps53 or HCCS1 was shown to have analogous characteristics to the yeast homologue and co-localized with mannose-6-phosphate receptor, 27 which is the primary receptor for the lysosomal aspartyl protease cathepsin D. 28 Based on these observations, one may conceive that overexpressed HCCS1 induces the efflux of cathepsin D by executing an abnormal transport function in the endosomal/lysosomal system. However, the mechanism by which overexpressed HCCS1 induces the elevation of intracellular calcium is not yet clear. Studies to elucidate these mechanisms are in progress.
To our knowledge, few transport proteins have been demonstrated to play a role in apoptosis regulation or development. In this study, we have proved the induction of apoptosis by HCCS1 overexpression and have characterized the HCCS1-induced apoptotic cascade. Meanwhile, data from the present investigation implied a non-cell autonomous role of HCCS1 during placental development. Further research into the roles of HCCS1 as a transport protein and as a regulator of apoptosis may lead to new strategies for controlling the development and growth of tumors.
Materials and Methods
Cell lines and culture conditions. The human hepatoma cell line BEL7404 and SMMC-7721 was purchased from Shanghai Cell Collection (Chinese Academy of Science, Shanghai, China), and cultured at 371C in Dulbecco's modified Eagle's medium (HyClone, Logan, UT, USA) containing 10% fetal bovine serum. The intracellular calcium chelator, Bapta-AM, was purchased from BioMol (Plymouth Meeting, PA, USA) and used at final concentrations of 50 mM. The aspartic protease inhibitor, pepstatin A, was a product of Santa Cruz Biotechnology Inc. (Santa Cruz, CA, USA) and was used at a final concentration of 50 mM. The irreversible pan-caspase inhibitor, z-VAD-fmk, and the caspase-9 inhibitor, z-LEDHfmk, were purchased from R&D systems (Minneapolis, MN, USA), and both were used at final concentrations of 50 mM. BIP V5 was purchased from Calbiochem (La Jolla, CA, USA) and used at a final concentration of 200 mM. Dimethylsulfoxide (DMSO; Sigma-Aldrich Co., St. Louis, MO, USA) was used at a corresponding dilution as a solvent control.
Generation of adenoviral vectors and infection procedure. The HCCS1 cDNA was obtained as described previously.
1 Ad-HCCS1, a replicationdeficient adenovirus that expresses HCCS1, and Ad-EGFP were constructed in adherence with the technical protocol of the AdEasy vector system (Strategene, La Jolla, CA, USA). Ad is a control recombinant adenovirus that does not carry any transgene but has the same adenovirus backbone as Ad-HCCS1. The presence of the transgene in the finally isolated viral stock was confirmed by PCR. The recombinant adenoviruses were titrated by a plaque assay. Infection with Ad-HCCS1 and Ad was accomplished by incubating the cells at a multiplicity of infection of 50 in serum-free medium for 2 h, followed by addition of the medium containing 10% serum and further incubation for the required time at 371C.
Analysis of apoptosis by Annexin V/PI staining. Infected cells were washed, resuspended in the staining buffer, and examined with Annexin V-FITC Apoptosis Detection kit (KeyGen Biotech Co., Nanjing, China) according to the manufacturer's instructions. Stained cells were analyzed by FACS (FACScalibur; Becton Dickinson, Mountain View, CA, USA).
Subcellular fractionation and western blot analyses. Whole-cell lysates and cytosolic and mitochondrial fractions were prepared and subjected to western blot analysis as described previously. 29 Blots were probed with anticaspase-3, anti-actin, anti-AIF, anti-cathepsin D (Santa Cruz Biotechnology), Figure 7 Proposed mechanisms of HCCS1-induced apoptosis. In this model, HCCS1 overexpression causes the lysosomal efflux of cathepsin D, which then induces cytosolic Bax insertion into the mitochondrial membrane followed by cytochrome c release from mitochondria. Mitochondrial Bax is cleaved partially to produce p18 Bax, which can accelerate the apoptotic process. Meanwhile, HCCS1 overexpression also causes [Ca 2 þ ] i elevation, which in turn leads to cytochrome c release. Released cytochrome c induces the activation of downstream caspases and late stages of apoptosis anti-PARP, anti-caspase-9, anti-Bid, anti-Bax (Cell Signaling Technology, Beverly, MA, USA), anti-caspase-8 (Chemicon, Temecula, CA, USA), and anti-caspase-12 (Calbiochem).
Alkaline extraction. The mitochondrial fractions from infected cells were resuspended in 0.1 M Na 2 CO 3 (pH 11.5), incubated for 30 min on ice, and then centrifuged (75 000 Â g, 20 min). The pellet was analyzed by western blotting as an alkali-resistant fraction.
Analysis of Dw m . Infected cells were stained with the fluorochrome JC-1 (1.25 mg/ml; Molecular Probes) according to the previous study. 30 The membrane potential was measured by using FACS. JC-1 aggregates were detected at 585 nm and JC-1 monomers at 530 nm.
was performed by using an intracellular free Ca 2 þ fluorescent probe, Flou-3/AM (Molecular Probes), as described previously. 31 Flou-3/AM-loaded cells were examined by confocal microscopy (TCS SP2; Leica Microsystems). [Ca 2 þ ] i levels were analyzed by Leica confocal software (Leica Microsystems) and represented by fluorescent intensity.
Lysosomal stability assessment. Lysosomal stability assessment was performed by using LysoTrack Red (Molecular Probes) that accumulates in lysosomes on the basis of low pH. Cells were incubated with 50 nM LysoTrack Red for 30 min. Nuclei were stained with DAPI and cells were examined by confocal microscopy (TCS SP2; Leica Microsystems).
Targeting construct. Mouse genomic DNA for vector construction was extracted from ES cells that were from the 129/SvcJ7 strain. An approximately 2.5 kb KpnI/XbaI genomic fragment containing a part of exon 1 and an approximately 3 kb SalI/NotI fragment containing a part of exon 2 were subcloned into the pPNT plasmid (provided by Dr. Pandolffi, Sloan-kettering Institute for Cancer Research, New York, NY, USA). Both fragments were cloned on both sides of a neomycin-resistance cassette (Figure 5a ), and the targeting vector was linearized with NotI.
Targeting/genotyping. Electroporation of the construct into ES cells from the 129/SvcJ7 strain (passage 13) and selection for homologous recombinants were performed according to standard procedures. We screened targeted ES colonies using Southern blot and generated chimeric mice. These were mated with C57BL/ 6J wild-type mice, and the offspring were genotyped using PCR. Primers A (5 0 -ACTCAGGCAATCCTCAAGTG-3 0 ) and B (5 0 -AGAGAAATGGAAGAAGCCGC ACTA-3 0 ) were used to detect wild-type alleles. The targeted allele was detected using primers A and C (5 0 -GCGTGCAATCCATCTTGTTC-3 0 ).
Histological analysis of placentae. Placentae isolated from pregnant mice were fixed in 4% paraformaldehyde, embedded in paraffin, and serially sectioned at 5 mm. The sections were stained with hematoxylin and eosin as per standard procedures. Sections for the detection of endogenous alkaline phosphatase activity were prepared as described previously, 32 and incubated with 5-bromo-4-chloro-3-indolylphosphate/nitroblue tetrazolium in Tris buffer (pH 9.5). Alkaline phosphatase activity resulted in blue staining. For PCNA immunohistochemical staining, sections were de-paraffinized using xylene, and rehydrated in a graded series of ethanol with a final wash in distilled water. Antigen retrieval was carried out by boiling the sections in 10 mM citrate buffer (pH 6.0) for 15 min. Endogenous peroxidase activity was blocked by treating the sections with 3% H 2 O 2 , followed by incubation with mouse monoclonal anti-PCNA antibody (Santa Cruz Biotechnology) at 41C overnight. After being washed with PBS, the primary antibody was detected using the ChemMate DAKO EnVision Detection kit, peroxidase/DAB, rabbit/mouse (DAKO, Glostrup, Denmark) according to the manufacturer's protocol. The sections were then counterstained with hematoxylin, dehydrated, and mounted.
Statistical analysis. The statistical significance of difference between various groups was analyzed by using analysis of variance (ANOVA) and Student-NewmanKeuls test for multiple comparisons. Statistical analysis was performed using the statistical software SPSS11.5. Differences among groups were regarded as significant if Po0.05.
